Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06537128 · ClinicalTrials.gov registry record · NA

Internet-delivered Cognitive-Behavioral Therapy for Adolescents With Autism and Anxiety

A NA study of Anxiety and Autism Spectrum Disorder, sponsored by Baylor College of Medicine.

Recruiting
Registry status
NA
Development phase
139
Enrollment target
1
Study location

NCT06537128: Recruiting NA study of Anxiety and Autism Spectrum Disorder, sponsored by Baylor College of Medicine.

NCT06537128 is a NA study of Anxiety and Autism Spectrum Disorder that is actively recruiting participants, run by Baylor College of Medicine. The registered enrollment target is 139 participants, below the 440-participant average among 364 other Anxiety trials with a reported enrollment target (68% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06537128, a NA study of Anxiety and Autism Spectrum Disorder, is actively recruiting participants, sponsored by Baylor College of Medicine.

RECRUITING
Registry status
NA
Development phase
139 participants
Enrollment target
1
Study location

Study Summary

Anxiety is very common in autistic youth. Cognitive behavioral therapy (CBT) is the recommended treatment for both autistic and typically-developing (TD) youth with anxiety, yet most families cannot access CBT due to cost, practicalities of attending in-person treatment sessions, and a shortage of trained providers, especially in rural areas. The goal of this project is to increase access to care for families of autistic adolescents with anxiety through an internet-based treatment model.

Primary Outcome

Clinician-rated child anxiety severity throughout the past week. Each item is scored on a 0 to 5 scale (higher scores correspond to greater severity), yielding a total between 0 and 35. This measure has been modified for autistic youth

Conditions Studied

Anxiety Autism Spectrum Disorder Autism Anxiety Disorders Generalized Anxiety Disorder Social Anxiety Disorder

Interventions

  • BEHAVIORAL Treatment as Usual
  • BEHAVIORAL LUNA-Adolescent

Study Locations (1)

Texas

  • Baylor College of Medicine - Houston

Trial Details

FieldValue
Enrollment Target 139 participants
Start Date 2024-11-01
Est. Completion 2026-04
Phase NA
Baylor College of Medicine

616 total trials

What NCT06537128 shows while recruiting

NCT06537128 is an interventional study that assigns participants to a tested intervention. The registered 139 participants enrollment target is mid-sized for trials with a published cap, below the 440-participant average among 364 other Anxiety trials with a reported enrollment target (68% lower).

The record links to 6 conditions, with Anxiety appearing as the primary indexed condition, and to 2 interventions - of which Treatment as Usual is the first listed.

NCT06537128 reports a single indexed study location in Texas.

Frequently Asked Questions

What is clinical trial NCT06537128 about?

NCT06537128 is a clinical study titled "Internet-delivered Cognitive-Behavioral Therapy for Adolescents With Autism and Anxiety". Anxiety is very common in autistic youth. Cognitive behavioral therapy (CBT) is the recommended treatment for both autistic and typically-developing (TD) youth with anxiety, yet most families cannot access CBT due to cost, practicalities of attending in-person treatment sessions, and a shortage of t...

What is the current status of trial NCT06537128?

This trial is currently recruiting. It is a NA study. The enrollment target is 139 participants. The study started on 2024-11-01. Estimated completion is 2026-04.

What conditions does trial NCT06537128 study?

This clinical trial studies the following conditions: Anxiety, Autism Spectrum Disorder, Autism, Anxiety Disorders, Generalized Anxiety Disorder.

What interventions are being tested in trial NCT06537128?

The interventions under investigation include: Treatment as Usual (BEHAVIORAL), LUNA-Adolescent (BEHAVIORAL).

Who is sponsoring clinical trial NCT06537128?

This trial is sponsored by Baylor College of Medicine, which has 616 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06537128 being conducted?

This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Anxiety

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT06537128's enrollment target sits among peer trials

139 131st of 364 higher than 233 of 364 other Anxiety trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Anxiety trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT05645380 · 139 participants · Phase 2

    Neoadjuvant TIL- and Response-Adapted Chemoimmunotherapy for TNBC

  • NCT06239272 · 139 participants · Phase 1

    NRSTS2021, A Risk Adapted Study Evaluating Maintenance Pazopanib, Limited Margin, Dose-Escalated Radiation Therapy and Selinexor in Non-Rhabdomyosarcoma Soft Tissue Sarcoma (NRSTS)

  • NCT06252220 · 139 participants · Phase 1

    First in Human Study in Subjects With Obesity, But Otherwise Healthy

  • NCT01419561 · 140 participants · Phase 2

    Natural History Study of the KSHV Inflammatory Cytokine Syndrome (KICS)

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

More recruiting context for NCT06537128

Source: ClinicalTrials.gov NCT06537128, the US trial registry maintained by the National Library of Medicine. NCT06537128 (mid enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.